Business Standard

CureVac becomes second company to test Covid-19 vaccine in Germany: Report

The World Health Organization lists 11 experimental coronavirus vaccines as currently being tested on humans, according to a table posted on its website

A health worker wearing protective gloves signs a swab sample vial at a Maharaja Bir Bikram Airport after the government allowed domestic flight services to resume, during an extended nationwide lockdown to slow the spread of the coronavirus disease
Premium

A health worker wearing protective gloves signs a swab sample vial at a Maharaja Bir Bikram Airport after the government allowed domestic flight services to resume, during an extended nationwide lockdown to slow the spread of the coronavirus disease

Ludwig Burger and Patricia Weiss | Reuters Frankfurt
The unlisted biotech firm CureVac will become the second company to launch human trials of an experimental coronavirus vaccine in Germany, two people familiar with the plans told Reuters on Tuesday.
The clinical trial, to be announced on Wednesday, is the second to be approved by Germany's vaccines regulator, the Paul Ehrlich Institute, after a trial by BioNTech that began in April.
CureVac and the Paul Ehrlich Institute declined to comment.
The World Health Organization lists 11 experimental coronavirus vaccines as currently being tested on humans, according to a table posted on its website.
The German government on Monday unveiled a deal to take

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 17 2020 | 1:29 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com